Latest News
ValueSetters Takes Equity Ownership Stake in Vymedic to Strengthen Portfolio
Friday 16 October 2020

US-based financial technology company ValueSetters, Inc. (OTC: VSTR) has taken an equity ownership stake in US-based biotechnology firm, adding Vymedic to its portfolio, the company said.
Terms of the transaction were not disclosed.

Vymedic is currently engaged in a round of equity fundraising via Netcapital.

ValueSetters will partner with Vymedic to advance its patented approach to helping millions impacted by influenza, the common cold and other viruses.

Vymedic's patented immune supplement, Vymune, has been scientifically proven to suppress influenza, the common cold and similar viruses.

The product has also been shown to be safer and more effective than competing antiviral drugs or supplements. Vymune's all natural, amino acid-based formula will be available in rapid melt away tablets, sold over the counter.

ValueSetters is dedicated to democratising private capital markets and empowering entrepreneurs to succeed.
Date Published: 16/10/2020